BRIDGET SHAW: Open Payments
NPI 1285204719 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 15 payments from 8 companies in 2025. Trend: 2023 $220 · 2024 $250 · 2025 $469
Food & beverage: $284Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $137 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| GENZYME CORPORATION | 2 | $75 |
| Galderma Laboratories, L.P. | 3 | $48 |
| LEO Pharma Inc. | 2 | $39 |
| Amgen Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
Products named: DUPIXENT, TREMFYA, ANZUPGO, OTEZLA, NEMLUVIO, EBGLYSS, ILUMYA.
Industry payments across AZ — which companies pay providers there.
